Teva Pharma Industries Ltd ADR (TEVA)

8.55
-0.07(-0.81%)
After Hours
8.60
+0.05(+0.58%)
- Real-time Data
  • Volume:
    8,644,774
  • Day's Range:
    8.40 - 8.64
  • 52 wk Range:
    6.78 - 11.34

TEVA Overview

Prev. Close
8.62
Day's Range
8.4-8.64
Revenue
14.93B
Open
8.6
52 wk Range
6.78-11.34
EPS
-1.17
Volume
8,644,774
Market Cap
9.5B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
8,864,783
P/E Ratio
-7.66
Beta
1.27
1-Year Change
7.08%
Shares Outstanding
1,110,644,809
Next Earnings Date
Feb 15, 2023
What is your sentiment on Teva ADR?
or
Market is currently closed. Voting is open during market hours.

Teva Pharma Industries Ltd ADR News

Teva Pharma Industries Ltd ADR Analysis

Teva Pharma Industries Ltd ADR Company Profile

Teva Pharma Industries Ltd ADR Company Profile

Employees
35346

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company’s products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Read More

Analyst Price Target

Average9.70 (+13.45% Upside)
High13
Low7
Price8.55
No. of Analysts10
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellBuyStrong SellStrong SellStrong Sell
SummaryStrong SellNeutralStrong SellStrong SellStrong Sell
  • Got FDA approval for drugs which is 1000 times stronger than morphine, they will push sales and prescription to people who don’t need it or who doesn’t have cancer so stock might go up but it will burst as well and be carried away by some new name! Like cephola and Insys did. Good luck
    0
    • not sure...
      0
      • not sure...
        0
        • What’s going on with $teva
          0
          • nice. very good company
            0